References

Estradiol valerate

Aedo, A.-R., Landgren, B.-M., & Diczfalusy, E. (1990). Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women. Maturitas, 12(4), 333–343. https://doi.org/10.1016/0378-5122(90)90013-V

Aedo, A.-R., Landgren, B.-M., Johannisson, E., & Diczfalusy, E. (1985). Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations. Contraception, 31(5), 453–469. https://doi.org/10.1016/0010-7824(85)90081-2

Blackwell, R. E., Boots, L. R., & Potter, H. D. (1982). Evaluation of Delestrogen and Parlodel as a luteolytic agent in humans. Fertility and Sterility, 37(2), 213–217. https://doi.org/10.1016/S0015-0282(16)46042-5

B.Q.F.Doris Del Cisne Valle Alvarez. (2011). Efecto de una Dosis de 50 mg de Enantato de Noretisterona y 5 mg de Valerato de Estradiol en los Niveles de Testosterona Total en Hombres Mexicanos Sanos.

Düsterberg, B., & Nishino, Y. (1982). Pharmacokinetic and pharmacological features of oestradiol valerate. Maturitas, 4(4), 315–324. https://doi.org/10.1016/0378-5122(82)90064-0

Düsterberg, B., Schmidt-Gollwitzer, M., & Hümpel, M. (2008). Pharmacokinetics and Biotransformation of Estradiol Valerate in Ovariectomized Women. Hormone Research, 21(3), 145–154. https://doi.org/10.1159/000180039

Düsterberg, B., & Wendt, H. (2008). Plasma Levels of Dehydroepiandrosterone and 17β-Estradiol after Intramuscular Administration of Gynodian-Depot® in 3 Women. Hormone Research, 17(2), 84–89. https://doi.org/10.1159/000179680

Garza-Flores, J. (1994). Pharmacokinetics of once-a-month injectable contraceptives. Contraception, 49(4), 347–359. https://doi.org/10.1016/0010-7824(94)90032-9

Geppert, G. (1975). Untersuchungen zur Pharmakokinetik von Östradiol-17 beta, Östradiol-Benzoat, Östradiol-Valerianat und Östradiol-Undezylat bei der Frau: Der Verlauf der Konzentrationen von Östradiol-17 beta, Östron, LH und FSH im Serum. Verlag nicht ermittelbar.

Goh, H. H., & Ratnam, S. S. (1988). Review: The LH surge in humans: its mechanism and sex difference. Gynecological Endocrinology, 2(2), 165–182. https://doi.org/10.3109/09513598809023624

Goh, H. H., & Ratnam, S. S. (1990). Effect of estrogens on prolactin secretion in transsexual subjects. Archives of Sexual Behavior, 19(5), 507–516. https://doi.org/10.1007/BF02442351

Goh, V. H. H., & Lee, K. O. (1998). Does a Positive Oestrogen Feedback on the Hypothalamic-Pituitary Axis Exist Concurrently with a Defective Testosterone Feedback in Klinefelter’s Syndrome? Hormone Research in Paediatrics, 50(3), 160–165. https://doi.org/10.1159/000023266

Göretzlehner, G., Bergmann, G., Angelow, K., Ackermann, W., Kliem, O., Bieck, E., & Golbs, S. (2002). Pharmakokinetik von Estron, Estradiol, FSH, LH und Prolaktin nach intramuskulärer Applikation von 5 mg Estradiolvalerat.

Jilma, B., Eichler, H. G., Breiteneder, H., Wolzt, M., Aringer, M., Graninger, W., Röhrer, C., Veitl, M., & Wagner, O. F. (1994). Effects of 17 beta-estradiol on circulating adhesion molecules. The Journal of Clinical Endocrinology & Metabolism, 79(6), 1619–1624. https://doi.org/10.1210/jcem.79.6.7527406

Kerdelhué, B., Andrews, M. C., Zhao, Y., Scholler, R., & Jones, H. W. (2006). Short term changes in melatonin and cortisol serum levels after a single administration of estrogen to menopausal women.

Oriowo, M. A. (1980). Comparison of the Pharmacokinetic Properties of Three Estradial Esters. Contraception.

Rauramo, L., Punnonen, R., & Grönroos, M. (1981). Serum concentrations of oestrone, oestradiol and oestriol during various oestrogen treatments. Maturitas, 3(2), 183–186. https://doi.org/10.1016/0378-5122(81)90010-4

Rauramo, L., Punnonen, R., Kaihola, H.-L., & Grönroos, M. (1980). Serum oestrone, oestradiol and oestriol concentrations in castrated women during intramuscular oestradiolvalerate and oestradiolbenzoate-oestradiolphenylpropionate therapy. Maturitas, 2(1), 53–58. https://doi.org/10.1016/0378-5122(80)90060-2

Reimann, I. W., Britzelmeier, C., Haber, P., Wollmann, H., Antonin, K. H., & Bieck, P. R. (1987). Influence of oestradiol on alpha2-adrenoceptor binding sites on intact platelets of young male volunteers. European Journal of Clinical Pharmacology, 33(2), 147–150. https://doi.org/10.1007/BF00544558

Sherwin, B. B. (1988). Affective changes with estrogen and androgen replacement theraphy in surgically menopausal women. Journal of Affective Disorders, 14(2), 177–187. https://doi.org/10.1016/0165-0327(88)90061-4

Sherwin, B. B., Gelfand, M. M., Schucher, R., & Gabor, J. (1987). Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations. American Journal of Obstetrics and Gynecology, 156(2), 414–419. https://doi.org/10.1016/0002-9378(87)90295-X

Somerville, B. W. (1971). The influence of progesterone and oestradiol on migraine [[object Object]]. https://doi.org/10.26190/UNSWORKS/10779

Somerville, B. W. (1972a). The Influence of Hormones Upon Migraine in Women. Medical Journal of Australia, 2(S2), 6–11. https://doi.org/10.5694/j.1326-5377.1972.tb93039.x

Somerville, B. W. (1972b). The Influence of Progesterone and Estradiol Upon Migraine. Headache: The Journal of Head and Face Pain, 12(3), 93–102. https://doi.org/10.1111/j.1526-4610.1972.hed1203093.x

Somerville, B. W. (1972c). The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology, 22(4), 355–355. https://doi.org/10.1212/WNL.22.4.355

Somerville, B. W. (1975). Estrogen‐withdrawal migraine: I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology, 25(3), 239–239. https://doi.org/10.1212/WNL.25.3.239

Vermeulen, A. (1975). Longacting Steroid Preparations. Acta Clinica Belgica, 30(1), 48–55. https://doi.org/10.1080/17843286.1975.11716973

Estradiol enanthate

Benagiano, G., Bianchi, P., Von Kesserü, E., Castañeda, A., Correa, J. E., & Martínez, G. (1995). Session 19 what is new about injectable contraceptives? Advances in Contraception, 11(1), 39–42. https://doi.org/10.1007/BF02436100

Garza-Flores, J. (1994). Pharmacokinetics of once-a-month injectable contraceptives. Contraception, 49(4), 347–359. https://doi.org/10.1016/0010-7824(94)90032-9

Garza-Flores, J., Alba, V. M., Cravioto, M. C., Hernandez, L., Perez-Palacios, G., Alvarado, G., Rivera, R., Recio, R., & Bassol, S. (1989). Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin. Contraception, 39(5), 519–529. https://doi.org/10.1016/0010-7824(89)90107-8

Recio, R., Garza-Flores, J., Schiavon, R., Reyes, A., Diaz-Sanchez, V., Valles, V., De La Cruz, D. L., Oropeza, G., & Perez-Palacios, G. (1986). Pharmacodynamic assessment of dihydroxyprogesterone acetophenide plus estradiol enanthate as a monthly injectable contraceptive. Contraception, 33(6), 579–589. https://doi.org/10.1016/0010-7824(86)90046-6

Schiavon, R., Benavides, S., Oropeza, G., Garza-Flores, J., Recio, R., Díaz-Sanchez, V., & Pérez-Palacios, G. (1988). Serum estrogens and ovulation return in chronic users of a once-a-month injectable contraceptive. Contraception, 37(6), 591–598. https://doi.org/10.1016/0010-7824(88)90005-4

Wiemeyer, J. C., Fernandez, M., Moguilevsky, J. A., & Sagasta, C. L. (1986). Pharmacokinetic studies of estradiol enantate in menopausic women. Arzneimittel-Forschung, 36(11), 1674–1677.

Wiemeyer, J. C. M., Fernandez, M., Sagasta, C. L., & Moguilevsky, J. A. (1987). Estudos farmacocinéticos do enantato de estradiol em mulheres na menopausa. J. bras. ginecol, 497–501.

Estradiol cypionate

Buckman, M. T., Johnson, J., Ellis, H., Srivastava, L., & Peake, G. T. (1980). Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate. Metabolism, 29(9), 803–805. https://doi.org/10.1016/0026-0495(80)90117-1

Lichten, E. M., Lichten, J. B., Whitty, A., & Pieper, D. (1996). The Confirmation of a Biochemical Marker for Women’s Hormonal Migraine: The Depo‐Estradiol Challenge Test. Headache: The Journal of Head and Face Pain, 36(6), 367–371. https://doi.org/10.1046/j.1526-4610.1996.3606367.x

Oriowo, M. A. (1980). Comparison of the Pharmacokinetic Properties of Three Estradial Esters. Contraception.

Rahimy, M. H., Ryan, K. K., & Hopkins, N. K. (1999). Lunelle^TM monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): Steady-state pharmacokinetics of MPA and E2 in surgically sterile women. Contraception, 60(4), 209–214. https://doi.org/10.1016/S0010-7824(99)00086-4

Rosenfield, R. L., & Fang, V. S. (1974). The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teen-agers. The Journal of Pediatrics, 85(6), 830–837. https://doi.org/10.1016/S0022-3476(74)80355-0

Rosenfield, R. L., Fang, V. S., Dupon, C., Kim, M. H., & Refetoff, S. (1973). The Effects of Low Doses of Depot Estradiol and Testosterone in Teenagers with Ovarian Failure and Turner’s Syndrome. The Journal of Clinical Endocrinology & Metabolism, 37(4), 574–580. https://doi.org/10.1210/jcem-37-4-574

Sierra-Ramírez, J. A., Lara-Ricalde, R., Lujan, M., Velázquez-Ramírez, N., Godínez-Victoria, M., Hernádez-Munguía, I. A., Padilla, A., & Garza-Flores, J. (2011). Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg). Contraception, 84(6), 565–570. https://doi.org/10.1016/j.contraception.2011.03.014

Thurman, A., Kimble, T., Hall, P., Schwartz, J. L., & Archer, D. F. (2013). Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: Steady-state pharmacokinetics. Contraception, 87(6), 738–743. https://doi.org/10.1016/j.contraception.2012.11.010

Estradiol benzoate

Bider, D., Ben-Rafael, Z., Shalev, J., Goldenberg, M., Mashiach, S., & Blankstein, J. (1989). Pituitary and ovarian suppression rate after high dosage of gonadotropin-releasing hormone agonist. Fertility and Sterility, 51(4), 578–581. https://doi.org/10.1016/S0015-0282(16)60602-7

Braun, P., Wildt, L., & Leyendecker, G. (1983). The effect of danazol on gonadotropin secretion during the follicular phase of the menstrual cycle. Fertility and Sterility, 40(1), 37–44. https://doi.org/10.1016/S0015-0282(16)47174-8

Canales, E. S., Cabezas, A., Vázquez-Matute, L., & Zárate, A. (1978). Induction of Ovulation with Clomiphene and Estradiol Benzoate in Anovulatory Women Refractory to Clomiphene Alone. Fertility and Sterility, 29(5), 496–499. https://doi.org/10.1016/S0015-0282(16)43271-1

Canales, E. S., Fonseca, M. e., Mason, M., & Zárate, A. (1981). Feedback effect of estradiol on follicle-stimulating hormone and prolactin secretion during the puerperium. International Journal of Gynecology & Obstetrics, 19(1), 79–81. https://doi.org/10.1016/0020-7292(81)90043-6

Cano, A., Gimeno, F., Fuente, T., Parrilla, J. J., & Abad, L. (1986). The positive feedback of estradiol on gonadotropin secretion in women with perimenopausal dysfunctional uterine bleeding. European Journal of Obstetrics & Gynecology and Reproductive Biology, 22(5–6), 353–358. https://doi.org/10.1016/0028-2243(86)90125-5

Eriksson, O., Bäckström, T., Stridsberg, M., Hammarlund-Udenaes, M., & Naessén, T. (2006). Differential response to estrogen challenge test in women with and without premenstrual dysphoria. Psychoneuroendocrinology, 31(4), 415–427. https://doi.org/10.1016/j.psyneuen.2005.10.004

Goodman, R. E., Anderson, D. C., Bu’lock, D. E., Sheffield, B., Lynch, S. S., & Butt, W. R. (1985). Study of the effect of estradiol on gonadotrophin levels in untreated male-to-female transsexuals. Archives of Sexual Behavior, 14(2), 141–146. https://doi.org/10.1007/BF01541659

Kemeter, P., Bernaschek, G., Altmann, G., & Feichtinger, W. (1984). The effect of 2 mg estradiol-17β plus 1 mg estriol, sequentially combined with 1 mg norethisteroneacetate, on LH, FSH, estradiol-17β, progesterone, testosterone and prolactin after ovarectomy. Archives of Gynecology, 234(3), 219–229. https://doi.org/10.1007/BF00570759

Keye, W. R., Jr., & Jaffe, R. B. (1975). Strength-Duration Characteristics of Estrogen Effects on Gonadotropin Response to Gonadotropin-Releasing Hormone in Women. I. Effects of Varying Duration of Estradiol Administration. The Journal of Clinical Endocrinology & Metabolism, 41(6), 1003–1008. https://doi.org/10.1210/jcem-41-6-1003

Leyendecker, G., Wildt, L., Gips, H., Nocke, W., & Plotz, E. J. (1976). Experimental studies on the positive feedback effect of progesterone, 17α-hydroxyprogesterone and 20α-dihydroprogesterone on the pituitary release of LH and FSH in the human female. Archiv Für Gynäkologie, 221(1), 29–45. https://doi.org/10.1007/BF00667679

Messinis, I. E., & Templeton, A. (1987a). Effect of High Dose Exogenous Oestrogen on Midcycle Luteinizing Hormone Surge in Human Spontaneous Cycles. Clinical Endocrinology, 27(4), 453–459. https://doi.org/10.1111/j.1365-2265.1987.tb01173.x

Messinis, I. E., & Templeton, A. A. (1987b). Disparate effects of endogenous and exogenous oestradiol on luteal phase function in women. Reproduction, 79(2), 549–554. https://doi.org/10.1530/jrf.0.0790549

Oriowo, M. A., Landgren, B.-M., Stenström, B., & Diczfalusy, E. (1980). A comparison of the pharmacokinetic properties of three estradiol esters. Contraception, 21(4), 415–424. https://doi.org/10.1016/S0010-7824(80)80018-7

Schweikert, H. U., Weissbach, L., Leyendecker, G., Schwinger, E., Wartenberg, H., & Krück, F. (1982). Clinical, Endocrinological, and Cytological Characterization of Two 46,XX Males*. The Journal of Clinical Endocrinology & Metabolism, 54(4), 745–752. https://doi.org/10.1210/jcem-54-4-745

Shaw, R. W. (1978). Neuroendocrinology of the menstrual cycle in humans. Clinics in Endocrinology and Metabolism, 7(3), 531–559. https://doi.org/10.1016/S0300-595X(78)80008-5

Shaw, R. W., Butt, W. R., & London, D. R. (1975). The Effect of Oestrogen Pretreatment on Subsequent Response to Luteinizing Hormone Releasing Hormone in Normal Women. Clinical Endocrinology, 4(3), 297–304. https://doi.org/10.1111/j.1365-2265.1975.tb01537.x

Shaw, R. W., Butt, W. R., London, D. R., & Marshall, J. C. (1975). The Oestrogen Provocation Test: A Method of Assessing the Hypothalamic‐Pituitary Axis in Patients with Amenorrhoea. Clinical Endocrinology, 4(3), 267–276. https://doi.org/10.1111/j.1365-2265.1975.tb01534.x

Travaglini, P., Ambrosi, B., Beck-Peccoz, P., Elli, R., Rondena, M., Bara, R., & Weber, G. (1978). Hypothalamic-pituitary-ovarian function in hyperprolactinemic women. Journal of Endocrinological Investigation, 1(1), 39–45. https://doi.org/10.1007/BF03346769

Travaglini, P., Elli, R., Ambrosi, B., Ballabio, M., Moriondo, P., & Faglia, G. (1979). Serum LH increase after estradiol and progesterone administration in hyperprolactinemic women. Journal of Endocrinological Investigation, 2(4), 407–411. https://doi.org/10.1007/BF03349341

Valimäki, M., Pelkonen, R., Salaspuro, M., Härkönen, M., Hirvonen, E., & Ylikahri, R. (1984). Sex Hormones in Amenorrheic Women with Alcoholic Liver Disease. The Journal of Clinical Endocrinology & Metabolism, 59(1), 133–138. https://doi.org/10.1210/jcem-59-1-133

Vizziello, G., D’Amato, G., Trentadue, R., & Fanizza, G. (1993). [Estradiol benzoate test in the study of pituitary block induced by triptorelin]. Minerva Ginecologica, 45(4), 185–189.

White, M. C., Rosenstock, J., Anapliotou, M., Mashiter, K., & Joplin, G. F. (1981). Heterogeneity of Prolactin Responses to Oestradiol Benzoate in Women with Prolactinomas. The Lancet, 317(8235), 1394–1396. https://doi.org/10.1016/S0140-6736(81)92571-X

合阪幸三, 安藤三郎, 國保健太郎, 吉田浩介, & 森宏之. (1986). いわゆる潜在性高prolactin血症患者におけるprolactin分泌予備能の検討. 日本内分泌学会雑誌, 62(5), 662–671. https://doi.org/10.1507/endocrine1927.62.5_662

角沖久夫. (1987). ヒト排卵機構とGonadotropin分泌調節における “β-Endorphinおよびβ-Lipotropin” の役割に関する研究. 日本内分泌学会雑誌, 63(10), 1289–1307. https://doi.org/10.1507/endocrine1927.63.10_1289

References

Estradiol valerate

Estradiol enanthate

Estradiol cypionate

Estradiol benzoate

Estradiol undecylate

Transdermal patches